As Nam Tai Ppty (NTP) Market Value Declined, Prescott Group Capital Management Boosted Stake by $675,000; Cvs Health (CVS) Holder Putnam Fl Investment Management Co Decreased Its Position as Stock Value Declined

CVS Health Corporation (NYSE:CVS) Logo

Putnam Fl Investment Management Co decreased its stake in Cvs Health Corporation (CVS) by 83.95% based on its latest 2018Q3 regulatory filing with the SEC. Putnam Fl Investment Management Co sold 56,890 shares as the company’s stock declined 3.04% with the market. The institutional investor held 10,873 shares of the medical and nursing services company at the end of 2018Q3, valued at $856,000, down from 67,763 at the end of the previous reported quarter. Putnam Fl Investment Management Co who had been investing in Cvs Health Corporation for a number of months, seems to be less bullish one the $87.43 billion market cap company. The stock increased 0.89% or $0.6 during the last trading session, reaching $67.61. About 4.61 million shares traded. CVS Health Corporation (NYSE:CVS) has risen 3.17% since February 13, 2018 and is uptrending. It has outperformed by 3.17% the S&P500. Some Historical CVS News: 06/03/2018 – S&PGR Assigns ‘BBB’ Issue-Level Rating to CVS Acquisition-Related Notes; 27/03/2018 – Rep. Davis: Employees at CVS, Best Buy, & Starbucks All Seeing Benefits of Tax Reform; 26/04/2018 – CVS Health Underscores Commitment to Safe Medication Disposal Ahead of National Prescription Drug Take-Back Day on April 28; 28/03/2018 – GOTTLIEB SAYS BIOSIMILARS MARKET WILL BE “SLOW BUILD”, BIGGEST IMPEDIMENT IS MARKET ACCESS; 17/04/2018 – AETNA – GIVEN PENDING DEAL WITH CVS HEALTH, CO WILL NOT HOST CONF CALL IN CONJUNCTION WITH EARNINGS RELEASE & DOES NOT EXPECT TO DO SO FOR FUTURE QTRS; 02/05/2018 – CVS Health 1Q Rev $45.69B; 22/03/2018 – Moody’s Affirms Three and Upgrades One Class of GMAC 1999-C2; 11/04/2018 – CVS Health to Provide Info, Tools to Choose Lower-Cost Prescription Drugs; 22/05/2018 – Thousands of Patients’ HIV-Positive Status Revealed by CVS – Class Action Lawsuit Filed; 19/03/2018 – ClinicalTrial US: Applying Nutrient Drink Test in Understanding Pathophysiology of CVS

Prescott Group Capital Management Llc increased its stake in Nam Tai Ppty Inc (NTP) by 23.04% based on its latest 2018Q3 regulatory filing with the SEC. Prescott Group Capital Management Llc bought 75,000 shares as the company’s stock declined 9.44% with the market. The hedge fund held 400,480 shares of the industrial machinery and components company at the end of 2018Q3, valued at $3.95 million, up from 325,480 at the end of the previous reported quarter. Prescott Group Capital Management Llc who had been investing in Nam Tai Ppty Inc for a number of months, seems to be bullish on the $329.92 million market cap company. The stock increased 1.15% or $0.1 during the last trading session, reaching $8.78. About 1,101 shares traded. Nam Tai Property Inc. (NYSE:NTP) has declined 30.20% since February 13, 2018 and is downtrending. It has underperformed by 30.20% the S&P500. Some Historical NTP News: 10/04/2018 – NAM TAI PROPERTY INC – TOTAL CONSTRUCTION COST FOR NAM TAI INNO PARK IS ESTIMATED TO BE $312 MLN; PLANNED CAPITAL INVESTMENT FOR 2018 IS $132.9 MLN; 10/04/2018 – Nam Tai Property Entered Into $184M Financing Package for Construction of Nam Tai Inno Park-; 10/04/2018 – NAM TAI PROPERTY INC – ENTERED INTO US$184 MLN FINANCING PACKAGE FOR CONSTRUCTION OF NAM TAI INNO PARK WITH CHINA CONSTRUCTION BANK CORPORATION; 10/04/2018 – NAM TAI PROPERTY – FINANCING PACKAGE CONSISTS OF FIXED ASSET LOAN AGREEMENT BETWEEN CCB AND ZASTRON SHENZHEN; 10/04/2018 – Nam Tai Property Inc. Announces Financing Package for the Construction of Nam Tai Inno Park and Date of Earnings Release; 23/05/2018 – Nam Tai Property Inc. Announces the Selection of Main Contractors for Nam Tai lnno Park; 16/03/2018 Nam Tai Property Inc. Filed Annual Report on Form 20-F for 2017 with SEC on March 9, 2018; 23/05/2018 – Nam Tai Property Inc. Announces the Selection of Main Contractors for Nam Tai Inno Park; 30/04/2018 – Nam Tai Property 1Q EPS 7c; 10/04/2018 – Nam Tai Property Inc. Announces Financing Package for the Construction of Nam Tai lnno Park and Date of Earnings Release

Prescott Group Capital Management Llc, which manages about $576.56 million and $510.40 million US Long portfolio, decreased its stake in Gp Strategies Corp (NYSE:GPX) by 95,108 shares to 64,910 shares, valued at $1.09M in 2018Q3, according to the filing. It also reduced its holding in Hilton Grand Vacations Inc by 27,200 shares in the quarter, leaving it with 8,250 shares, and cut its stake in Nu Skin Enterprises Inc (NYSE:NUS).

More notable recent Nam Tai Property Inc. (NYSE:NTP) news were published by: Fool.com which released: “Why Shares of Nam Tai Property Inc. Are Soaring Today – The Motley Fool” on July 12, 2017, also Seekingalpha.com with their article: “Nam Tai Electronics: Compelling Land Lease Trade – Seeking Alpha” published on January 17, 2014, Seekingalpha.com published: “Rover’s Notice To Proceed: Time To Unleash The Northeast? – Seeking Alpha” on February 15, 2017. More interesting news about Nam Tai Property Inc. (NYSE:NTP) were released by: Prnewswire.com and their article: “Nam Tai Property Inc. Announces Brand Launching Event – PR Newswire” published on November 02, 2018 as well as Globenewswire.com‘s news article titled: “Civeo Reports Third Quarter 2018 Results and Announces Initial Room Commitments at Sitka Lodge in Kitimat, B.C. – GlobeNewswire” with publication date: October 31, 2018.

Since August 27, 2018, it had 0 insider buys, and 9 insider sales for $34.16 million activity. 8,564 CVS Health Corporation (NYSE:CVS) shares with value of $642,300 were sold by Hourican Kevin. 166,368 shares were sold by MERLO LARRY J, worth $10.73M. 77,639 shares were sold by Roberts Jonathan C, worth $5.01M. Brennan Troyen A sold $1.17 million worth of CVS Health Corporation (NYSE:CVS) on Wednesday, November 14. The insider Denton David M sold 25,159 shares worth $2.02M. $1.72M worth of stock was sold by Bisaccia Lisa on Monday, October 1.

Investors sentiment increased to 1.12 in 2018 Q3. Its up 0.05, from 1.07 in 2018Q2. It increased, as 76 investors sold CVS shares while 459 reduced holdings. 144 funds opened positions while 456 raised stakes. 828.14 million shares or 1.36% more from 816.99 million shares in 2018Q2 were reported. Summit Asset Mngmt holds 0.18% or 4,850 shares in its portfolio. Finemark Financial Bank & has 0.05% invested in CVS Health Corporation (NYSE:CVS). Tci Wealth Incorporated stated it has 19,721 shares. Evercore Wealth Mgmt Llc invested 0.08% of its portfolio in CVS Health Corporation (NYSE:CVS). Addison Cap reported 21,920 shares. Moreover, Rhumbline Advisers has 0.3% invested in CVS Health Corporation (NYSE:CVS). New York-based Omega Advsr has invested 1.34% in CVS Health Corporation (NYSE:CVS). Focused Ltd Liability Co stated it has 4.88% of its portfolio in CVS Health Corporation (NYSE:CVS). Bbva Compass National Bank & Trust, a Texas-based fund reported 45,172 shares. Calamos Advisors Lc stated it has 159,279 shares. Chilton Mgmt Limited Liability reported 4,870 shares. Hourglass holds 0.17% of its portfolio in CVS Health Corporation (NYSE:CVS) for 8,153 shares. 16,200 are held by Tiverton Asset Ltd. Lee Danner And Bass Inc holds 0.35% of its portfolio in CVS Health Corporation (NYSE:CVS) for 44,899 shares. Bkd Wealth Ltd Liability has invested 0.04% in CVS Health Corporation (NYSE:CVS).

Putnam Fl Investment Management Co, which manages about $1.28 billion and $1.09B US Long portfolio, upped its stake in Automatic Data Processing Inc (NASDAQ:ADP) by 7,801 shares to 27,140 shares, valued at $4.09 million in 2018Q3, according to the filing. It also increased its holding in Marathon Petroleum Corp. (NYSE:MPC) by 14,200 shares in the quarter, for a total of 23,615 shares, and has risen its stake in Boeing Co. (NYSE:BA).

Among 28 analysts covering CVS Health (NYSE:CVS), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. CVS Health had 86 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, August 8 by Oppenheimer. Robert W. Baird maintained the stock with “Hold” rating in Thursday, February 8 report. The firm has “Buy” rating by Bank of America given on Monday, September 17. The firm earned “Hold” rating on Friday, September 15 by Jefferies. The stock has “Buy” rating by RBC Capital Markets on Thursday, February 8. The firm earned “Buy” rating on Tuesday, January 30 by Needham. The firm has “Hold” rating by Wolfe Research given on Wednesday, August 16. S&P Research maintained CVS Health Corporation (NYSE:CVS) on Monday, November 2 with “Strong Buy” rating. RBC Capital Markets maintained the stock with “Buy” rating in Monday, December 4 report. The rating was maintained by Leerink Swann on Tuesday, November 21 with “Buy”.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 14. They expect $2.14 earnings per share, up 11.46% or $0.22 from last year’s $1.92 per share. CVS’s profit will be $2.77B for 7.90 P/E if the $2.14 EPS becomes a reality. After $1.73 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 23.70% EPS growth.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “Walmart to exit CVS drugstore network – Seeking Alpha” on January 15, 2019, also 247Wallst.com with their article: “Walgreens ‘Top Violator’ Among Pharmacies for Selling Tobacco Products to Minors: FDA – 24/7 Wall St.” published on February 08, 2019, Finance.Yahoo.com published: “Bulls & Bears Of The Week: CVS, EA, GM, Kinder Morgan And More – Yahoo! Finance News” on January 20, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: 247Wallst.com and their article: “Top Analyst Upgrades and Downgrades: Alcoa, Cars.com, CVS, Electronic Arts, Halliburton, PNC, Salesforce, Walgreens, UnitedHealth and More – 24/7 Wall St.” published on January 17, 2019 as well as Fool.com‘s news article titled: “Better Buy: Walgreens Boots Alliance vs. CVS Health – Motley Fool” with publication date: January 19, 2019.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart